1 | 0.9% sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [4] 6 6, 14, 51, 53 💬 |
2 | 10% intravenous immunoglobulin (IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 💬 |
3 | 10% liquid formulation of human immunoglobulin | - | - | - | - | [1] 14 14 💬 |
4 | : immunoglobulina umana normale 10% per somministrazione endovenosa | - | - | - | - | [1] 14 14 💬 |
5 | Act-HiB | [1] Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | - | - | - | [4] 14 14, 61, 62, 222 💬 |
6 | Acthar | [1] Corticotropin Corticotropin | [1] Corticotropin
Corticotropin
💬 | [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [9] 2 2, 13, 14, 46, 49, 50, 66, 84, 222 💬 |
7 | Albumin (Human) 25%, United States Pharmacopeia (USP) | - | - | - | - | [2] 13 13, 14 💬 |
8 | Anti-C5 antibody | - | - | - | - | [4] 11 11, 14, 62, 109 💬 |
9 | Anti-Thymocyte Globulin | - | - | - | - | [18] 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬 |
10 | ARGX-113 | - | - | - | - | [5] 11 11, 14, 35, 53, 63 💬 |
11 | ARGX-117 | - | - | - | - | [1] 14 14 💬 |
12 | ARGX-117 IV | - | - | - | - | [1] 14 14 💬 |
13 | Batoclimab | [1] Batoclimab Batoclimab | [1] Batoclimab
Batoclimab
💬 | [1] FCGRT FCGRT 💬 | - | [2] 11 11, 14 💬 |
14 | Batoclimab 340 mg SC weekly | [1] Batoclimab Batoclimab | [1] Batoclimab
Batoclimab
💬 | [1] FCGRT FCGRT 💬 | - | [2] 11 11, 14 💬 |
15 | Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly | [1] Batoclimab Batoclimab | [1] Batoclimab
Batoclimab
💬 | [1] FCGRT FCGRT 💬 | - | [1] 14 14 💬 |
16 | Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 💬 |
17 | BIVV020 | - | - | - | - | [2] 14 14, 61 💬 |
18 | Carmustine | [1] Carmustine Carmustine | [1] Carmustine
Carmustine
💬 | - | - | [5] 11 11, 13, 14, 28, 60 💬 |
19 | Chloride | [1] Chloride ion Chloride ion | - | - | - | [28] 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 💬 |
20 | Clorfenamina | [1] Chlorpheniramine Chlorpheniramine | [1] Chlorphenamine
Chlorphenamine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 14 14 💬 |
21 | CLORFENAMINA MALEATO | [1] Chlorpheniramine Chlorpheniramine | [1] Chlorphenamine
Chlorphenamine
💬 | [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 14 14 💬 |
22 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬 | - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬 |
23 | Cytarabine | [1] Cytarabine Cytarabine | [1] Cytarabine
Cytarabine
💬 | - | - | [7] 11 11, 13, 14, 25, 49, 60, 65 💬 |
24 | Dexamethasone | [1] Dexamethasone Dexamethasone | [1] Dexamethasone
Dexamethasone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [22] 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬 |
25 | Drug: | - | - | - | - | [3] 14 14, 46, 113 💬 |
26 | ECULIZUMAB | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [7] 11 11, 13, 14, 61, 62, 109, 222 💬 |
27 | EFGARTIGIMOD ALFA | [1] Efgartigimod alfa Efgartigimod alfa | [1] Efgartigimod alfa
Efgartigimod alfa
💬 | [1] FCGRT FCGRT 💬 | - | [6] 11 11, 14, 35, 53, 63, 162 💬 |
28 | Efgartigimod PH20 SC | - | - | - | - | [5] 11 11, 14, 35, 63, 162 💬 |
29 | Efgartigimod PH20 SC in stage B | - | - | - | - | [1] 14 14 💬 |
30 | Etoposide | [1] Etoposide Etoposide | [1] Etoposide
Etoposide
💬 | [2] TOP2A TOP2A, TOP2B 💬 | [1] Platinum drug resistance Platinum drug resistance 💬 | [11] 11 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬 |
31 | FAMPRIDINE | [1] Dalfampridine Dalfampridine | [1] Dalfampridine
Dalfampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [2] 13 13, 14 💬 |
32 | FAMPYRA | [1] Dalfampridine Dalfampridine | [1] Dalfampridine
Dalfampridine
💬 | [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [2] 13 13, 14 💬 |
33 | Fibrinogen | [1] Fibrinogen human Fibrinogen human | - | - | - | [2] 14 14, 65 💬 |
34 | Fibrinogen concentrate | [1] Fibrinogen human Fibrinogen human | - | - | - | [1] 14 14 💬 |
35 | FINGOLIMOD | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬 | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 13 13, 14, 156 💬 |
36 | FINGOLIMOD HYDROCHLORIDE | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬 | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 14 💬 |
37 | Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 43, 45 💬 |
38 | FTY720 | - | - | - | - | [2] 13 13, 14 💬 |
39 | FTY720I | - | - | - | - | [1] 14 14 💬 |
40 | Gammanorm | - | - | - | - | [2] 14 14, 65 💬 |
41 | Gilenya | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬 | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [3] 2 2, 13, 14 💬 |
42 | GILENYA 0,5 mg cápsulas duras | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬 | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 14 14 💬 |
43 | Group C meningococcal conjugate vaccine | - | - | - | - | [1] 14 14 💬 |
44 | H.P. Acthar® Gel | [1] Corticotropin Corticotropin | [1] Corticotropin
Corticotropin
💬 | [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 14 14 💬 |
45 | HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) | [1] Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | - | - | - | [2] 13 13, 14 💬 |
46 | Haemophilus type b vaccine (conjugated) | - | - | - | - | [1] 14 14 💬 |
47 | HB-adMSCs | [1] Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - | - | [5] 2 2, 6, 13, 14, 46 💬 |
48 | Hematopoietic Stem Cell Transplantation | - | - | - | - | [12] 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
49 | Hidrocloruro de fingolimod | [1] Fingolimod Fingolimod | [1] Fingolimod
Fingolimod
💬 | [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 14 💬 |
50 | Hizentra | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 14 14, 50, 51, 65 💬 |
51 | Hizentra® | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [2] 14 14, 65 💬 |
52 | HUMAN IMMUNOGLOBULIN G | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 14 14, 50, 63, 65 💬 |
53 | Human normal 10% immunoglobulin for intravenous administration | - | - | - | - | [1] 14 14 💬 |
54 | Human normal 10% immunoglobulin for intravenous administrationn | - | - | - | - | [1] 14 14 💬 |
55 | Human normal immunoglobulin | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [9] 11 11, 13, 14, 43, 45, 50, 51, 63, 65 💬 |
56 | HUMAN NORMAL IMMUNOGLOBULIN (IV) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 11 11, 14, 63, 65 💬 |
57 | Human normal immunoglobulin (IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 50, 65 💬 |
58 | Human normal immunoglobulin (SCIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 💬 |
59 | Human normal immunoglobulin for intravenous administration | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 51, 65 💬 |
60 | Human normal immunoglobulin G (IgG > 98% purity) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 63, 65 💬 |
61 | Hyaluronidase | [2] Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) | [3] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬 | - | - | [5] 14 14, 28, 51, 65, 331 💬 |
62 | HyQvia | [2] Human immunoglobulin G Human immunoglobulin G, Hyaluronidase (human recombinant) | - | - | - | [2] 14 14, 65 💬 |
63 | I10 | - | - | - | - | [1] 14 14 💬 |
64 | I10E | - | - | - | - | [3] 14 14, 63, 65 💬 |
65 | IGIV, 10% | - | - | - | - | [2] 14 14, 65 💬 |
66 | IgPro10 | - | - | - | - | [3] 14 14, 51, 65 💬 |
67 | IgPro20 | - | - | - | - | [4] 14 14, 50, 51, 65 💬 |
68 | IgPro20 (high dose) | - | - | - | - | [1] 14 14 💬 |
69 | IgPro20 (low dose) | - | - | - | - | [1] 14 14 💬 |
70 | IGVENA*FL 200ML 10G+SET | - | - | - | - | [2] 14 14, 50 💬 |
71 | Immune globulin | - | - | - | - | [3] 11 11, 13, 14 💬 |
72 | Immune Globulin 10% Intravenous Solution | - | - | - | - | [1] 14 14 💬 |
73 | Immune Globulin Intravenous (human), 10% | - | - | - | - | [2] 14 14, 65 💬 |
74 | Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified | - | - | - | - | [1] 14 14 💬 |
75 | Immune Globulin Subcutaneous (Human) | - | - | - | - | [2] 14 14, 65 💬 |
76 | Immunoglobulin | - | - | - | - | [3] 13 13, 14, 63 💬 |
77 | IMMUNOGLOBULIN G | - | - | - | - | [8] 2 2, 11, 13, 14, 49, 50, 63, 65 💬 |
78 | Immunoglobulin perfusion | - | - | - | - | [1] 14 14 💬 |
79 | IMMUNOGLOBULINA UMANA NORMALE per somministrazione endovenosa | - | - | - | - | [1] 14 14 💬 |
80 | Immunoglobuline G | - | - | - | - | [1] 14 14 💬 |
81 | Immunoglobulins | - | - | - | - | [1] 14 14 💬 |
82 | Immunoglobulins, normal human, for extravascular adm. | - | - | - | - | [1] 14 14 💬 |
83 | Immunoglobulins, normal human, for intravascular adm. | - | - | - | - | [2] 14 14, 15 💬 |
84 | Intratect | - | - | - | - | [4] 13 13, 14, 35, 65 💬 |
85 | Intravenous immune globulin G | - | - | - | - | [1] 14 14 💬 |
86 | Intravenous Immunoglobulin | - | - | - | - | [7] 13 13, 14, 35, 38, 39, 51, 309 💬 |
87 | Intravenous immunoglobulin (IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 14 14, 17, 164, 296 💬 |
88 | IQYMUNE | - | - | - | - | [1] 14 14 💬 |
89 | IVIG | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [7] 11 11, 13, 14, 17, 50, 51, 65 💬 |
90 | J07AH07 | - | - | - | - | [1] 14 14 💬 |
91 | KIOVIG | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [2] 14 14, 65 💬 |
92 | KIOVIG 100 mg/ml solution for infusion | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [2] 14 14, 65 💬 |
93 | Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 14 14 💬 |
94 | Lipoic acid | [1] Lipoic acid Lipoic acid | - | - | - | [5] 2 2, 5, 13, 14, 20 💬 |
95 | MabThera | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [22] 11 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
96 | MABTHERA - 1 FIALA 500 MG 50 ML | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [2] 14 14, 53 💬 |
97 | MD1003 | - | - | - | - | [5] 2 2, 10, 13, 14, 20 💬 |
98 | Melphalan | [1] Melphalan Melphalan | [1] Melphalan
Melphalan
💬 | - | - | [15] 11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
99 | Menjugate | - | - | - | - | [1] 14 14 💬 |
100 | Methylprednisolon | [1] Methylprednisolone Methylprednisolone | [1] Methylprednisolone
Methylprednisolone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [4] 13 13, 14, 51, 66 💬 |
101 | Methylprednisolon (Solu-Medrol) | [1] Methylprednisolone Methylprednisolone | [1] Methylprednisolone
Methylprednisolone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 14 14 💬 |
102 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [1] Methylprednisolone
Methylprednisolone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [46] 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
103 | Methylprednisolone (Solu-Medrol) | [1] Methylprednisolone Methylprednisolone | [1] Methylprednisolone
Methylprednisolone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 14 14 💬 |
104 | Metilprednisolone sodio succinato | - | - | - | - | [3] 13 13, 14, 56 💬 |
105 | N. MENINGITIDIS GROUP C POLYSACCHARIDE | - | - | - | - | [1] 14 14 💬 |
106 | NewGam | - | - | - | - | [3] 14 14, 63, 65 💬 |
107 | Nipocalimab | [1] Nipocalimab Nipocalimab | [1] Nipocalimab
Nipocalimab
💬 | [1] FCGRT FCGRT 💬 | - | [6] 11 11, 14, 46, 49, 53, 61 💬 |
108 | NPB-01 | - | - | - | - | [3] 13 13, 14, 162 💬 |
109 | PANZYGA | - | - | - | - | [1] 14 14 💬 |
110 | PARACETAMOLO | - | - | - | - | [9] 2 2, 11, 14, 19, 28, 53, 61, 63, 300 💬 |
111 | Placebo | - | - | - | - | [28] 3 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
112 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) | - | - | - | - | [2] 13 13, 14 💬 |
113 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [42] 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
114 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬 |
115 | Prevenar 13 | [12] Streptococcus pneumoniae type 1 capsular polysaccharide antigen Streptococcus pneumoniae type 1 capsular polysaccharide antigen, Streptococcus pneumoniae type 14 capsular polysaccharide antigen, Streptococcus pneumoniae type 18c capsular polysaccharide antigen, Streptococcus pneumoniae type 19a capsular polysaccharide antigen, Streptococcus pneumoniae type 19f capsular polysaccharide antigen, Streptococcus pneumoniae type 23f capsular polysaccharide antigen, Streptococcus pneumoniae type 3 capsular polysaccharide antigen, Streptococcus pneumoniae type 4 capsular polysaccharide antigen, Streptococcus pneumoniae type 5 capsular polysaccharide antigen, Streptococcus pneumoniae type 6b capsular polysaccharide antigen, Streptococcus pneumoniae type 7f capsular polysaccharide antigen, Streptococcus pneumoniae type 9v capsular polysaccharide antigen | - | - | - | [5] 13 13, 14, 46, 96, 222 💬 |
116 | Prevenar 13 sospensione per iniezione | [12] Streptococcus pneumoniae type 1 capsular polysaccharide antigen Streptococcus pneumoniae type 1 capsular polysaccharide antigen, Streptococcus pneumoniae type 14 capsular polysaccharide antigen, Streptococcus pneumoniae type 18c capsular polysaccharide antigen, Streptococcus pneumoniae type 19a capsular polysaccharide antigen, Streptococcus pneumoniae type 19f capsular polysaccharide antigen, Streptococcus pneumoniae type 23f capsular polysaccharide antigen, Streptococcus pneumoniae type 3 capsular polysaccharide antigen, Streptococcus pneumoniae type 4 capsular polysaccharide antigen, Streptococcus pneumoniae type 5 capsular polysaccharide antigen, Streptococcus pneumoniae type 6b capsular polysaccharide antigen, Streptococcus pneumoniae type 7f capsular polysaccharide antigen, Streptococcus pneumoniae type 9v capsular polysaccharide antigen | - | - | - | [1] 14 14 💬 |
117 | PRIVIGEN | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 11 11, 14, 51, 65 💬 |
118 | Privigen® | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 63, 65 💬 |
119 | Recombinant human hyaluronidase | [2] Hyaluronidase Hyaluronidase, Hyaluronidase (human recombinant) | [3] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬 | - | - | [3] 14 14, 28, 65 💬 |
120 | RHuPH20 | - | - | - | - | [2] 13 13, 14 💬 |
121 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [48] 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
122 | Rituximab (genetical recombination) | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬 | [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 14 14 💬 |
123 | ROZANOLIXIZUMAB | [1] Rozanolixizumab Rozanolixizumab | [1] Rozanolixizumab
Rozanolixizumab
💬 | [1] FCGRT FCGRT 💬 | - | [3] 11 11, 14, 63 💬 |
124 | RVG 51680 | - | - | - | - | [1] 14 14 💬 |
125 | RVG 56083 | - | - | - | - | [1] 14 14 💬 |
126 | SAR445088 (formerly BIVV020) | - | - | - | - | [1] 14 14 💬 |
127 | SAR445088 (IV) | - | - | - | - | [1] 14 14 💬 |
128 | SAR445088 (SC) | - | - | - | - | [1] 14 14 💬 |
129 | Sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [20] 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 💬 |
130 | Sodium Chloride 0.9% | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬 | - | - | [2] 14 14, 227 💬 |
131 | SOLIRIS | [1] Eculizumab Eculizumab | [1] Eculizumab
Eculizumab
💬 | [1] C5 C5 💬 | [11] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [7] 11 11, 13, 14, 61, 62, 109, 222 💬 |
132 | SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML | - | - | - | - | [3] 13 13, 14, 53 💬 |
133 | Subcutaneous immune globulin G | - | - | - | - | [1] 14 14 💬 |
134 | Subcutaneous immunoglobulin | - | - | - | - | [1] 14 14 💬 |
135 | Subcuvia | - | - | - | - | [3] 14 14, 49, 65 💬 |
136 | TACHIPIRINA - 1000 MG COMPRESSE 8 COMPRESSE | - | - | - | - | [1] 14 14 💬 |
137 | TAK-771 | - | - | - | - | [2] 14 14, 65 💬 |
138 | Tetanus toxoid | [1] Clostridium tetani toxoid antigen (formaldehyde inactivated) Clostridium tetani toxoid antigen (formaldehyde inactivated) | - | - | - | [4] 13 13, 14, 46, 50 💬 |
139 | TRIMETON - 10 MG/1 ML SOLUZIONE INIETTABILE 5 FIALE 1 ML | - | - | - | - | [1] 14 14 💬 |
140 | UCB7665 | - | - | - | - | [3] 11 11, 14, 63 💬 |
141 | VACCINO PNEUMOCOCCICO SACCARIDICO | - | - | - | - | [1] 14 14 💬 |
142 | Vivaglobin | - | - | - | - | [2] 14 14, 65 💬 |